Recursion Provides Business Updates and Reports Third Quarter 2024 Financial Results
SALT LAKE CITY, Nov. 06, 2024 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today reported business updates and financial…